Skip to content

KeratoConus Data Acquisition With Topography and Aberrometry

Data Collection Study in Keratoconus, Utilizing Topography and Wavefront Aberrometry

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859398
Acronym
KC-DATA
Enrollment
52
Registered
2025-03-05
Start date
2025-06-16
Completion date
2025-11-20
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Ectasia, Keratoconus

Keywords

Keratoconus, Corneal ectasia, Wavefront aberrometry, Corneal topography, Scleral topography, Ocular topography, Irregular corneal condition

Brief summary

This observational study aims to collect real-world wavefront aberrometry and corneal/scleral topography data from individuals with keratoconus and other corneal ectatic disorders. This data will be used to develop and refine a methodology for designing custom-fitted scleral contact lenses with embedded active light management technology. The study will focus on characterizing the optical imperfections (aberrations) and corneal/scleral shape variations in this population to optimize lens design for improved vision and comfort.

Detailed description

Keratoconus, the most common corneal ectatic disease, and other related disorders are characterized by progressive thinning and steepening of the cornea, leading to distorted vision. This study will enroll individuals with these conditions to gather detailed information about their eyes using two non-invasive imaging techniques: Wavefront aberrometry: Measures optical imperfections (aberrations) that contribute to visual distortions like glare, halos, and reduced visual acuity. This data will help understand the specific optical challenges faced by individuals with keratoconus and inform the development of lenses that correct these aberrations. Ocular topography: Maps the three-dimensional shape of the cornea and sclera. The study will utilize advanced topography techniques to capture a wider scan of the ocular surface than is typically available. This expanded view is crucial for designing contact lenses that conform precisely to the irregular corneal shape in keratoconus (conformal fitting). The primary objective of this study is to gather this crucial data to inform the development of a methodology for designing a conformal, custom-fitted contact lens. This lens, being developed by Azalea Vision, will incorporate active light management technology and is intended to address the complex visual challenges experienced by individuals with keratoconus and other corneal ectatic disorders. The data collected will enable Azalea Vision to optimize lens design for improved vision, comfort, and overall quality of life for these individuals.

Interventions

OTHEROcular Topography and Wavefront Aberrometry

Eyescan with Pentacam AXL Wave

Sponsors

Azalea Vision
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

This study is considered as a data collection study. The data which will be collected within this study, is not collected per standard of care. Depending on the participating country, the study is considered interventional

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18y * Provide written Informed Consent * Diagnosed with keratoconus and/or any other type of ectatic corneal disorder * Cornea considered to be clinically stable at the discretion of the investigator (e.g. no recent cross linking performed, no current corneal sutures, no corneal sutures recently removed). * Willing to remove current contact lenses for a minimum of 48 hours prior to performing the pentacam AXL Wave scan, if applicable. Note: In case only 1 eye is diagnosed with keratoconus, both eyes will be scanned, as long as none of the

Exclusion criteria

apply to that eye

Design outcomes

Primary

MeasureTime frameDescription
Ocular Topographyduring the Eyescan procedureMapping of the ocular surface
Wavefront aberrometryduring the Eyescan procedureQuantification of the wavefront aberrations

Secondary

MeasureTime frameDescription
Anterior chamber depthduring the Eyescan procedureas measured by the Pentacam AXL Wave.
Axial lengthduring the Eyescan procedureas measured by the Pentacam AXL Wave
Ocular Topographyduring the Eyescan procedureDescription of the percentage of ocular surface mapped during topography measurement
Distribution level of keratoconus severityduring the Eyescan procedureusing the parameters embedded in the Oculus Pentacam AXL Wave
Pupillometryduring the Eyescan proceduremeasurement of pupil size during aberrometry measurement
Wavefront aberrometryduring the Eyescan procedureQuality of aberrometric measurements based on full sequence quality specification embedded in the Oculus Pentacam AXL Wave

Countries

Belgium, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026